Total Funding
9
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Nodality develops biologically-informed clinical treatments for patients with cancer and autoimmune diseases.
- Garry Nolan: Scientific Founder, Nodality IncPast Role: Rigel Networks, Scientific Founder, Rigel Inc.
- Kathleen LaPorte: Chief Business Officer
About the Company
Nodality, Inc., a biotechnology company, discovers and develops personal diagnostics characterizing cell signaling pathways in defined cellular sub-populations of malignant and normal cells from individual patients. The company focuses on hematological malignancies and autoimmune disorders. Nodality, Inc. was incorporated in 2003 and is based in
San Francisco, California with an additional office in Franklin, Tennessee.
